WFM
NVAX icon

Wilmington Funds Management’s Novavax NVAX Stock Holding History

Wilmington Funds Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$370K Hold
4,006
– – 0.04% 446
2014
Q1 		$363K Sell
4,006
-1,110
-22% -$124K 0.04% 456
2013
Q4 		$524K Sell
5,116
-257
-5% -$18.2K 0.05% 376
2013
Q3 		$340K Hold
5,373
– – 0.03% 518
2013
Q2 		$220K Buy
+5,373
New +$233K 0.02% 624

Other funds holding NVAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Wilmington Funds Management's NVAX Position: Q2 2014 in Review

Wilmington Funds Management held its Novavax (NVAX) position steady in Q2 2014 at 4,006 shares worth $370K. The position accounts for 0.04% of the portfolio, ranked #446.

Wilmington Funds Management first reported a position in NVAX in Q2 2013 and has held it in 5 quarters since. The position peaked at $524K in Q4 2013. 137 funds tracked by Wall St. Rank hold NVAX as of Q2 2014.

  • Wilmington Funds Management held 4,006 shares of Novavax worth $370K as of Q2 2014.
  • Wilmington Funds Management left its Novavax share count unchanged in Q2 2014.
  • Novavax made up 0.04% of Wilmington Funds Management's portfolio in Q2 2014, its #446 holding.
  • Wilmington Funds Management first reported a position in Novavax in Q2 2013 and has held it in 5 quarters since.
  • Wilmington Funds Management's Novavax position peaked at $524K in Q4 2013.
  • 137 funds tracked by Wall St. Rank held Novavax as of Q2 2014.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.